Navigation Links
Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
Date:2/25/2011

Company believes that no patients have been denied reimbursement for KRYSTEXXA.  
  • Staged Roll-out – During the first phase of the launch program, Savient sales teams will target  Rheumatologists and Nephrologists.  Savient anticipates the ramp-up to be slow in this initial phase as the Company conducts infusion center in-service education and works to speed the private and public payer reimbursement processes.  
  • Expanding market opportunities – Savient is on track to complete the EU submission for KRYSTEXXA in the first quarter of 2011 or shortly thereafter.  The Company then expects to execute plans to file in other markets around the world, including Asia where the prevalence of gout is among the highest in the world.

  • Fourth Quarter and Year-End 2010 Financial ResultsSavient also today reported financial results for the three months and year ended December 31, 2010.  Savient ended the quarter with $64.9 million in cash and short-term investments, a decrease of $13.2 million for the quarter and $43.3 million since December 31, 2009.

    For the fourth quarter 2010, the Company had a net loss of $0.5 million, or $0.01 per share, inclusive of a gain from a non-cash valuation adjustment of $18.1 million, relating to a previous warrant liability, on total revenues of $1.0 million.  This compares with a net loss of $0.2 million, or $0.00 per share, on total revenues of $0.9 million for the same period in 2009.

    The net loss for the year ended December 31, 2010 was $73.1 million, or $1.08 per share, on total revenues of $4.0 million, compared with a net loss of $90.9 million, or $1.51 per share, on total revenues of $3.0 million in 2009.  Savient ended 2010 with 70.3 million shares outstanding.

    Operational Highlights:

  • Closed the sale, on February 4, 2011, of $230 million in aggregate principal amount of 4.75% Convertible Senior Notes due 2018
    '/>"/>

  • SOURCE Savient Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011
    2. Savient Closes Sale of $230 Million in Convertible Senior Notes
    3. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
    4. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
    5. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
    6. Savient Pharmaceuticals Announces Search for CEO
    7. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
    8. Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
    9. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
    10. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
    11. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... and PHOENIX , Aug. ... to bring cutting-edge next-generation sequencing and proteomic diagnostics ... today announced a collaboration with TESARO, Inc.  Paradigm ... patient tissue samples from clinical trials to better ... to TESARO,s TSR-011.  This may lead to more successful ...
    (Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
    (Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
    Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
    ... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
    ... Motion Technologies,announced the completion of the first surgical ... System (TM) (TSMS(TM)), the first total,joint replacement system ... and posterior dynamic stabilization device (PDS). The,successful procedure ... Numune,Education and Training Hospital by Dr. Erkan Kaptanoglu, ...
    Cached Medicine Technology:European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2
    (Date:8/20/2014)... According to the new report “Engineering ... Fluor polymer, Polyamide, Polycarbonate, Polyoxymethylene, Thermoplastic Polyesters, ... & Forecasts (2013- 2018)”, defines and segments ... and forecasting of the global revenue and ... restraining factors for the global engineering plastics ...
    (Date:8/20/2014)... FL (PRWEB) August 20, 2014 Ticket Down ... tickets in Miami, FL at the Sun Life Stadium in ... football rivalry this September when Brazil and Colombia meet at Sun ... of the top 10 teams in the world and will be ... in Brazil. The match will kick-off on Sept. 5 and will ...
    (Date:8/20/2014)... IQ Formulations , a top national health and nutritional ... , distinguishing it as one of the fastest growing private ... the list, but was ranked in the top 50 by ... It also ranked ninth among all health companies, fifth among ... growing company in the Miami metro area. , Headquartered ...
    (Date:8/20/2014)... 2014 It’s no secret that millions ... the National Institute on Drug Abuse, nearly 24 million ... even more alarming is the fact that the total ... , Those locked in a struggle with substance abuse ... But now, the newly-redesigned AbuseTreatmentCenters.net has released updated lists ...
    (Date:8/20/2014)... 20, 2014 The Institute for ... is proud to announce its new partnership with ... a cutting-edge university offering graduate programs featuring flexible ... Program are now eligible to receive six graduate ... Health Studies. , “I’m so thrilled to announce ...
    Breaking Medicine News(10 mins):Health News:Engineering Plastics Market Worth $79,026.6 Million by 2018 – New Report by MarketsandMarkets 2Health News:Engineering Plastics Market Worth $79,026.6 Million by 2018 – New Report by MarketsandMarkets 3Health News:Engineering Plastics Market Worth $79,026.6 Million by 2018 – New Report by MarketsandMarkets 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 3Health News:Leading Health Supplement Company IQ Formulations Among Inc. Magazine’s Top 50 Fastest Growing Private Companies in the United States 2Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3
    ... (NYSE AMEX: ULU ) today announced ... The Company reported a net loss of $3.1 million, or ... or $0.03 per share, for the same period last year. ... of $5.1 million, compared with $7.6 million at December 31, 2009.Commenting ...
    ... Calif., May 15 Thoratec Corporation (Nasdaq: ... support therapies to save, support and restore failing hearts, ... former chief operating officer of Boston Scientific, to its ... shareholders at the company,s annual shareholders, meeting on May ...
    ... DALLAS, May 15 C. Richard Boland, M.D., chief ... at Dallas, has been named vice president of the ... evolve into the presidency in 2011. The oldest medical ... dedicated to advancing the science and practice of gastroenterology. ...
    ... The International Union for Health Promotion and ... (SOPHE) are pleased to release today special, complementary peer-reviewed ... assurance systems of global capacity in health promotion and ... Behavior (Vol. 36, No. 3, June 2009), and ...
    ... American Institute of Ultrasound in Medicine is pleased to ... Edition . All operators of ultrasound systems with an ... The book consists of 3 parts: Bioeffects and Biophysics, ... achievable). With the information from this 64 page publication, ...
    ... Nyer Medical Group, Inc. (Nasdaq: NYER ) ... 2009. Revenues for third quarter of fiscal 2009 increased ... as reported for the comparable quarter in the prior year. ... addition of five new pharmacies over the past 12 months. ...
    Cached Medicine News:Health News:ULURU Inc. Reports First Quarter 2009 Financial Results 2Health News:ULURU Inc. Reports First Quarter 2009 Financial Results 3Health News:ULURU Inc. Reports First Quarter 2009 Financial Results 4Health News:ULURU Inc. Reports First Quarter 2009 Financial Results 5Health News:ULURU Inc. Reports First Quarter 2009 Financial Results 6Health News:Thoratec Announces Appointment of Paul LaViolette to Board of Directors 2Health News:Thoratec Announces Appointment of Paul LaViolette to Board of Directors 3Health News:Dallas Gastroenterologist Named Vice President of Prestigious National Organization 2Health News:Special journal issues released on global health promotion and health education 2Health News:AIUM releases second edition of 'Medical Ultrasound Safety' 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 3Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 4Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 5
    Female Mini-VEST, Front Closure, X-Firm...
    This compression garment can be used following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction,Lipectomy, Stomach Liposuction, Liposculpture, TummyTuck....
    Ideal for lower abdominal procedures. Comes with a left side separating zipper....
    Provides upper and lower arm support. Extends to the lower arm and across the shoulders. Has two columns of hook & eye closure for added adjustability....
    Medicine Products: